EVOFEM BIOSCIENCE INC by Evofem Biosciences, Inc. Financials - Benzinga

EVOFEM BIOSCIENCE INC by Evofem Biosciences, Inc.

EVFMOTCID

Trade with Public

Trade with Public

$0.4782

-77.52-99.39%

At close: Aug 9, 5:00 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare

EVOFEM BIOSCIENCE INC by Evofem Biosciences, Inc. Financials

EVOFEM BIOSCIENCE INC by Evofem Biosciences, Inc. (EVFM) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Evofem Biosciences Q1 EPS $(0.04), Sales $899.000K Up From $845.000K YoY

Evofem Biosciences (OTC:EVFM) reported quarterly losses of $(0.04) per share. The company reported $899.000 thousand in sales this quarter. This is a 6.39 percent increase over sales of $845.000 thousand the same period

Benzinga Newsdesk

PRO
Evofem Biosciences Q3 EPS $(0.01) Up From $(0.02) YoY, Sales $4.952M Up From $4.496M YoY

Evofem Biosciences (OTC:EVFM) reported quarterly losses of $(0.01) per share. This is a 50 percent increase over losses of $(0.02) per share from the same period last year. The company reported $4.952 million in sales

Benzinga Newsdesk

PRO
Evofem Biosciences Q2 EPS $(0.02), Sales $4.825M Up From $4.160M YoY

Evofem Biosciences (OTC:EVFM) reported quarterly losses of $(0.02) per share. The company reported $4.825 million in sales this quarter. This is a 15.99 percent increase over sales of $4.160 million the same period last

Benzinga Newsdesk

PRO
Evofem Biosciences Q1 Sales $845.00K Down From $3.60M YoY

Evofem Biosciences (OTC:EVFM) reported $845.00 thousand in sales this quarter. This is a 76.55 percent decrease over sales of $3.60 million the same period last year.

Benzinga Newsdesk

Evofem Biosciences's Return On Capital Employed Insights

Benzinga Insights

Evofem Biosciences Return On Capital Employed Overview

Benzinga Insights